Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN493075 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 32 (IL32) antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide selective for IL32 from near carboxy terminal of IL32alfa
- Description
- Affinity Chromatography
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 0.1 mg
- Concentration
- 0.65-0.82 mg/mL
- Storage
- Store the antibody (in aliquots) at-20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Rheumatoid arthritis and interleukin-32.
Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.
Involvement of IL-32 in activation-induced cell death in T cells.
Proteinase 3 is an IL-32 binding protein.
IL-32, a proinflammatory cytokine in rheumatoid arthritis.
Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism.
IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.
Interleukin-32: a cytokine and inducer of TNFalpha.
The polymorphonuclear leukocyte.
Shoda H, Fujio K, Yamamoto K
Cellular and molecular life sciences : CMLS 2007 Oct;64(19-20):2671-9
Cellular and molecular life sciences : CMLS 2007 Oct;64(19-20):2671-9
Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.
Raymond WW, Cruz AC, Caughey GH
The Journal of biological chemistry 2006 Jan 20;281(3):1489-94
The Journal of biological chemistry 2006 Jan 20;281(3):1489-94
Involvement of IL-32 in activation-induced cell death in T cells.
Goda C, Kanaji T, Kanaji S, Tanaka G, Arima K, Ohno S, Izuhara K
International immunology 2006 Feb;18(2):233-40
International immunology 2006 Feb;18(2):233-40
Proteinase 3 is an IL-32 binding protein.
Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 28;103(9):3316-21
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 28;103(9):3316-21
IL-32, a proinflammatory cytokine in rheumatoid arthritis.
Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 28;103(9):3298-303
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 28;103(9):3298-303
Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism.
Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, Dinarello CA
PLoS medicine 2006 Aug;3(8):e277
PLoS medicine 2006 Aug;3(8):e277
IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.
Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH
Proceedings of the National Academy of Sciences of the United States of America 2005 Nov 8;102(45):16309-14
Proceedings of the National Academy of Sciences of the United States of America 2005 Nov 8;102(45):16309-14
Interleukin-32: a cytokine and inducer of TNFalpha.
Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA
Immunity 2005 Jan;22(1):131-42
Immunity 2005 Jan;22(1):131-42
The polymorphonuclear leukocyte.
Baggiolini M, Bretz U, Dewald B, Feigenson ME
Agents and actions 1978 Jan;8(1-2):3-10
Agents and actions 1978 Jan;8(1-2):3-10
No comments: Submit comment
No validations: Submit validation data